Today's Daily Dose brings you news about Array's progress in melanoma clinical program; Auris Medical's upcoming clinical trial catalyst; BeiGene's collaboration with Celgene; Merck's disappointing KEYNOTES; Prothena's PASADENA trial and Vivus' patent suit related to weight-loss drug Qsymia.
from RTT - Biotech http://ift.tt/2tPgK3p
via IFTTT
No comments:
Post a Comment